Listen to this post

I. Background:

(i) SEBI notified the Securities and Exchange Board of India (Mutual Funds) (Amendment) Regulations, 2023 (“Amendment”), on June 27, 2023. The Amendment follows a Consultation Paper on Review of Regulatory Framework for Sponsors of a Mutual Fund, which the SEBI had released on January 13, 2023 (“Consultation Paper”).

(ii) The Amendment strengthens the existing eligibility criteria for sponsors of a mutual fund, which requires sponsors to have vintage in the “business of financial services” (“Original Criteria”), and requires the sponsor to have,

a. a net profit in all of the preceding five years (as opposed to the erstwhile requirement of profit in three out of five years);

b. minimum average net profit of INR 10 crore in preceding five years; and

c. positive “liquid net worth” i.e. (cash, money market instruments, T-Bills and G-Secs), greater than the proposed capital contribution of such sponsor.

(iii) The Amendment also introduces alternate eligibility criteria (“Alternate Criteria”), which allows non-financial services entities and “a private equity fund or a pooled investment vehicle or a pooled investment fund”, to become sponsors, subject to,

a. capital infusion of INR 150 crore into the asset management company (“AMC”);

b. shareholding equivalent to the initial capitalisation of INR 150 crore to be locked-in for a period of five years;

c. appointment of experienced senior management officials, having a combined experience of at least 30 years; and

d. in cases of acquisition of an existing AMC, maintaining liquid net worth equal to the incremental capitalisation to bring the net worth of the AMC to INR 150 crore.

(iv) The Amendment provides a framework for ‘existing’ sponsors to “disassociate” from an AMC, basis conditions to be prescribed by SEBI, and subject to,

a. AMC having diversified shareholding (no single shareholder with more than 10% shareholding); and

b. AMC having 2/3rd independent board of directors (as opposed to the 50% independent board of directors for AMCs with a sponsor).

(v) The Amendment replicates many monitoring and investor protection responsibilities for the board of directors of the AMC, in addition to the trustees.

The amendments in Paragraphs I(ii), (iii) and (iv) above shall come into force on August 1, 2023, in Paragraph I(v) above shall come into force once it is notified by SEBI.

II. Analysis:

(i) Original Criteria:

a. INR 10 crore profit floor may impact smaller players; requirement to maintain positive “liquid net worth” may affect investment strategy at the sponsor level.

b. Given the August 1, 2023 enforcement date for Paragraph I(iii) above, greenfield applications/ brownfield acquisitions currently being contemplated, may be accelerated; but the status of pending sponsor applications with SEBI is unclear.

c. The exemption that had introduced a window for early stage Technology/ FinTech companies to ‘sponsor’ a mutual fund (i.e. by bringing INR 100 crore net worth, if the original criterion of profitability in three out of five years is not met), has been deleted. Loss-making early-stage players who have recently ‘sponsored’ mutual funds, either through fresh applications or acquisition of existing AMCs, will not have this flexibility going forward.

(ii) Alternate Criteria:

a. PE/ VC funds are now permitted to sponsor mutual funds, without support from a strategic player. This is a big move by SEBI.

b. The 40% shareholding lock-in requirement, as contemplated under the Consultation Paper, has been dropped, in favour of a blanket INR 150 crore capitalisation lock-in for five years. This may possibly enable sponsor “disassociation”for high net worth AMCs.  

c. “Sponsor-less” AMCs: Once SEBI prescribes the conditions, as mentioned in Paragraph I(iv) above, when a sponsor’s shareholding falls below 10%, “de-sponsorisation” will now be available (especially for listed AMCs), akin to “de-promoterisation”. Given the onerous ‘sponsor’ compliance requirements, this is a welcome step.

III. Implications:

EntityImplication
Strategic InvestorsHigher obligations imposed.  
PE / VC FundsPositive, PE/ VC funds can now ‘sponsor’ MF AMCs.  
Early Stage PlayersAs 3/5 years profitability exemption has been dropped, early stage players would have to explore alternative criteria.

IV. Conclusion:

Mutual Fund sector was the only space which lacked clarity on the status of financial sponsors. These Amendments are a step in the right direction as it will now enable PE/ VC funds to enter the Mutual Fund space as ‘sponsors’, and trigger fresh deal activity.

Fixing of a higher accountability on the board of directors of AMCs will help improve corporate governance standards, thereby benefitting investors/ unitholders.


Listen to this post
A Closer Look at India’s Pet Care Sector and Regulatory Grey Areas

In Part I of this series, titled ‘The (Pawsome) Pet Care Sector: Through a Legal Lens’, we provided a broad overview of the registration and compliance requirements for entities in the pet care industry. We also discussed factors like the entry options, the sector’s migration to the online mode, and relevant judicial pronouncements.

The legal framework for pet care in India is spread across a host of rules and legislations. The relevant regulatory duties are also divided between various regulators including the Food and Safety Standards Authority of India (“FSSAI”), the Central Drugs Standard Control Organisation (“CDSCO”), and the Animal Welfare Board of India, among others. Therefore, industry players will have to keep track of a wide range of legislations (along with relevant State rules and municipal laws) to ensure proper compliance.

Continue Reading Barking up the Right Tree: A Closer Look at India’s Pet Care Sector and Regulatory Grey Areas
Listen to this post

The pet-care sector has seen a massive growth in India, particularly during the pandemic. The sector is estimated to touch INR 10,000 crore by 2025[1], with the number of pets increasing at a rate of 11% per annum[2]. Healthcare services, nutrition, drugs, and pet-grooming form the core of the overall pet care sector.

Alongside growth, the pet care sector has witnessed a noticeable increase in competition with the entrance of several established as well as nascent players. Large organisations (like Emami) view investment in the pet-care sector as a favorable avenue for corporate diversification[3]. Owing to the specialised nature of the sector, the market trend appears to be one of strategic collaborations between large industry players and smaller organisations with niche focus areas. There are also collaborations between smaller organisations which aim to increase their reach and market share in the pet care sector – an example is the recent acquisition of Capt Zack (specializing in pet accessories) by Wiggles (specializing in pet food).

Continue Reading The (Pawsome) Pet Care Sector: Legal Insights
Listen to this post
What is the Cost of Environmental Breaches? A Look at the Evolving Jurisprudence of Environmental Compensation

The term ‘compensation’ has been legally defined by the Hon’ble Supreme Court to be a return for loss or damage sustained. The Court expressly states that compensation must always be just, and not based on a whim or arbitrary.[1]

Environmental compensation refers to payment of monetary reparation by industries, imposed by authorities and judicial bodies for violating environmental rules and regulations. The imposition of environmental compensation on industry finds its basis in the key environmental law principle of ‘Polluter Pays.’ The Polluter Pays Principle, simply put, makes the offending industry responsible for the damage caused to the environment and to human health.[2] In the 1990s, the Hon’ble Supreme Court of India began relying heavily on this principle to order industries to pay environmental compensation for breach of environmental regulations. [3]

Continue Reading What is the Cost of Environmental Breaches? A Look at the Evolving Jurisprudence of Environmental Compensation
Listen to this post

Background

On June 15, 2023, Securities and Exchange Board of India [“SEBI”] had released— (i) Master Circular for Investment Advisers; and (ii) Master Circular for Research Analysts.

The Master Circulars serve as comprehensive compilations of all directions issued by SEBI pertaining to Investment Advisers [“IAs”] and Research Analysts [“RAs“]. SEBI’s Master Circulars for IAs and RAs aim to provide easy access to relevant guidelines and promote compliance among IAs and RAs.

Continue Reading FIG Paper No. 22: Decoding SEBI’s Master Circular for Investment Advisers and Research Analysts
Listen to this post
Time spent in contractually mandated pre-arbitral negotiations not excluded

On 18th May 2023, a two-judge bench of the Supreme Court in B&T AG v. Ministry of Defence[1](“B&T”) ruled that mere negotiations, as in the case of a civil suit, will not postpone the cause of action for the purpose of computing limitation for initiation of arbitration[2].

This decision, although consistent with a long line of judgments in the context of computation of period of limitation for arbitral claims, waters down the progressive view taken by the Supreme Court in the case of Geo Miller & Co. Pvt. Ltd. v. Rajasthan Vidyut Utpadan Nigam Ltd.[3] (“Geo Miller”).

Continue Reading Time spent in contractually mandated pre-arbitral negotiations not excluded – SC in <em>B&T AG v Ministry of Defence</em>
Listen to this post

The ability to undertake corporate restructuring and M&A through private or statutory arrangements has served as a touchstone in deal making globally. Statutory arrangements, at times, offer several advantages over contractual/ private arrangements. There are, however, several commercial, legal and tax considerations that have to be considered before opting between a statutory and private arrangement. The speed and ease with which a business can undertake an arrangement also plays an important part in such decision-making. In India, private arrangement is more popular than statutory arrangement for undertaking M&A as the latter is contingent on receipt of regulatory authorisation. Statutory arrangements in India were initially permitted only by way of National Company Law Tribunal (“NCLT”) approval.

Continue Reading Mergers on a Fast-Track
Listen to this post
Scrutinising India’s Organ Donation Laws and the Dilemmas of ‘Brain-Stem Death’

A significant demand-supply gap plagues the market for organ donation in India. The country has one of the lowest organ donation rates in the world, resulting in the death of innumerable patients in need of organ transplants.[1] While a part of this problem can be attributed to lack of awareness among potential donors, the issue is exacerbated by legislative ambiguity and regulatory shortcomings. The law on organ donation in India is primarily governed by the Transplantation of Human Organs and Tissues Act, 1994 (as amended in 2014) (“Act”), read with the Transplantation of Human Organs and Tissues Rules, 2014 (“Rules”).

Continue Reading Beneath the Surface: Scrutinising India’s Organ Donation Laws and the Dilemmas of ‘Brain-Stem Death’
Listen to this post
Significance of Providing Un-Relied Documents to Accused An Indicator of a Fair Trial

One of the key facets of the criminal law regime is that an individual/ entity should be given a fair and transparent trial. Sections 207 and 208 of the Code of Criminal Procedure, 1973 (“CrPC”) are in furtherance to the said principle, which relate to providing copies of police report and other documents to accused persons.

Continue Reading Significance of Providing Un-Relied Documents to Accused: An Indicator of a Fair Trial
Listen to this post
The Operation of e-Pharmacies and Data Privacy Risks

E-Pharmacies and operations thereof have been a contentious issue for long. While the issue remains static largely due to the delay in the notification of the E-Pharmacy Rules that were drafted in 2018, there is significant litigation that has ensued as well. The Government is contemplating whether e-pharmacies should be allowed to sell medicines online and, in this vein, the Drugs Controller General of India (“DCGI”) has issued show-cause notices to over 20 e-pharmacies to give them an opportunity to explain their operations and compliance with the regulations. As litigation ensues and rival contentions are presented before the courts[1], the Indian Government is currently seeking proper legal opinion on the regulation of e-pharmacies.

Continue Reading The Operation of e-Pharmacies and Data Privacy Risks